Usana Health Sciences, Inc. (NYSE: USNA) reported Q4 EPS of $0.87, $0.01 better than the analyst estimate of $0.86. Revenue for the quarter came in at $145.9 million versus the consensus estimate of $144.4 million.

Usana Health Sciences, Inc. sees FY2012 EPS of $3.35-$3.45, versus the consensus of $3.52. Usana Health Sciences, Inc. sees FY2012 revenue of $600-$615 million, versus the consensus of $603.4 million.

For earnings history and earnings-related data on Usana Health Sciences, Inc. (USNA) click here.

Earnings Guidance